Spinal Cord Stimulation Restores Neural Function in SMA Patients
A groundbreaking clinical trial has demonstrated that spinal cord stimulation can help restore motor function in patients with spinal muscle atrophy (SMA), a severe neurodegenerative disease. Researchers at the University of Pittsburgh found that this drug-free, minimally invasive therapy improves muscle strength, walking ability, and fatigue levels, offering a new hope for treating neurodegenerative conditions.
Spinal Cord Stimulation: A New Approach to SMA Treatment
SMA is a genetic disorder that causes progressive loss of motor neurons, leading to severe muscle weakness and movement impairments. Current treatments, including gene therapy and medications, focus on slowing disease progression but do not reverse damage to nerve cells.
In this new study, researchers used spinalcord electrical stimulation to reactivate silent motor neurons, essentially rewiring neural connections to improve mobility and muscle function.
“To counteract neurodegeneration, we need two things—stop neuron death and restore function of surviving neurons,” said Dr. Marco Capogrosso, study co-author.
Clinical Trial Results: A Life-Changing Breakthrough
Three SMA patients participated in a 29-day pilot trial, undergoing spinalcord stimulation five times a week. The results were remarkable:
✔ All participants showed improved motor function
✔ Increased walking endurance by at least 20 meters
✔ Reduced fatigue and improved daily activity performance
✔ Improved motoneuron electrical function and strength
“Patients don’t expect to get better over time—but that’s exactly what we saw,” said Dr. Elvira Pirondini.
This therapy offers a potential alternative for other neurodegenerative diseases, including ALS and Huntington’s disease, by stimulating damaged neural pathways to restore movement.
Future Prospects: Expanding the Treatment
With encouraging early results, researchers plan to launch larger clinical trials to determine the long-term effectiveness of this approach. If successful, spinal cord stimulation could redefine treatment strategies for neurodegenerative diseases, providing millions of patients with renewed mobility and hope.
More Information: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy, Nature Medicine (2025). DOI: 10.1038/s41591-024-03484-8.
more recommended stories
Hypertensive Disorders of Pregnancy: Role of Daily ActivityKey Points Summary Limiting sedentary time.
Climate Change Drives Dengue Outbreaks GloballyKey Takeaways Extreme weather significantly increases.
Teen Driving Risks: Parents Underestimate Safety ThreatsKey Takeaways Teen driving risks remain.
PFK Enzyme Dual Role in Metabolism and Cell CycleKey Highlights Phosphofructokinase (PFK Enzyme) shows.
Exercise During Chemotherapy Supports Brain HealthKey Points Summary A nationwide clinical.
Stem Cell Therapies Course for Parkinson’s Disease CliniciansKey Summary The International Society for.
Invasive Cosmetic Procedures Raise Patient Safety ConcernsKey Summary Experts publishing in The.
Oligometastatic Pancreatic Cancer: New Global ConsensusKey Points Summary An international expert.
Endometriosis Screening Tool May Cut Diagnosis DelaysKey Points Researchers from the University.
Influenza Vulnerability Index Maps Flu Risk Across US StatesKey Points Researchers developed a new.

Leave a Comment